中文产业新闻精选评分69Chinese source
Moderna 个体化新抗原疗法 INTerpath-001 三期顶线阳性，国内仍处 I/II 期
治疗性癌症疫苗临床进展与管线格局：Moderna III期破局，国内卡位I/II期
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
治疗性癌症疫苗临床进展与管线格局：Moderna III期破局，国内卡位I/II期
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.